Margarete Akens

Dr. Margarete Akens

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
CFCarl J Fisher
Carl J Fisher
ZAZakariya Ali
Zakariya Ali
JDJay Detsky
Jay Detsky
ASArjun Sahgal
Arjun Sahgal
EDElizabeth David
Elizabeth David
AYAlbert J. Yee
Albert J. Yee
Introduction: Vertebroplasty (VP) and Balloon Kyphoplasty (KP) are minimally-invasive stabilization procedures for pathologic vertebral compression fractures (VCF). Concurrent administration of photodynamic therapy (PDT) as a tumour-ablative modality has yet to be studied in humans as a potential complement to improved mechanical stability that is afforded by vertebral cement augmentation (VCA). Patients and Methods:This first-in-human trial used a single 6 mg/m2 dose of the clinical photosensitizer Visudyne® with escalating laser light doses. Following a cohort of light-only controls (n=6), the drug and light treatment groups (n=6 each) were 50, 100, 150 and 200 J/cm. VCA was performed within 15 minutes following PDT. Patients were clinically reviewed at 1 and 6 weeks. The primary outcome measure was safety from a neurologic perspective. Results:Thirty patients comprising a variety of primary tumours were treated with PDT and either KP or VP. Vertebral PDT was technically feasible and delivered in all study patients. No dose groups showed significant increases in pain as defined by the generic SF-36 as well as disease-specific EORTC-QLQ-BM22 and EORTC-QLQ-C15-PAL questionnaires. The 50 and 100 J/cm groups showed the most significant pain reduction (p<0.05). Twelve (40%) patients experienced complications during the study including three patients with further vertebral fracture progression by 6 weeks despite VCA. No complications were directly attributed to PDT. Conclusion:Using the parameters described, vertebral PDT as an adjunct to VCA is safe from a pharmaceutical and neurologic perspective. The results of this trial motivate scale up study evaluating potential PDT efficacy in vertebral metastatic treatment.

30 December 2011 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
MHMichael Hardisty
Michael Hardisty
MAMargarete Akens
Margarete Akens
SHSeyed‐Parsa Hojjat
Seyed‐Parsa Hojjat
AYAlbert Yee
Albert Yee
CWCari Whyne
Cari Whyne
The vertebral column is the most frequent site of metastatic involvement of the skeleton with up to 1/3 of all cancer patients developing spinal metastases. Longer survival times for patients, particularly secondary to breast cancer, have increased the need for better understanding the impact of skeletal metastases on structural stability. This study aims to apply image registration to calculate strain distributions in metastatically involved rodent vertebrae utilizing µCT imaging. Osteolytic vertebral lesions were developed in five rnu/rnu rats 2–3 weeks post intracardiac injection with MT‐1 human breast cancer cells. An image registration algorithm was used to calculate and compare strain fields due to axial compressive loading in metastatically involved and control vertebrae. Tumor‐bearing vertebrae had greatly increased compressive strains, double the magnitude of strain compared to control vertebrae (p = 0.01). Qualitatively strain concentrated within the growth plates in both tumor bearing and control vertebrae. Most interesting was the presence of strain concentrations at the dorsal wall in metastatically involved vertebrae, suggesting structural instability. Strain distributions, quantified by image registration were consistent with known consequences of lytic involvement. Metastatically involved vertebrae had greater strain magnitude than control vertebrae. Strain concentrations at the dorsal wall in only the metastatic vertebrae, were consistent with higher incidence of burst fracture secondary to this pathology. Future use of image registration of whole vertebrae will allow focused examination of the efficacy of targeted and systemic treatments in reducing strains and the related risk of fracture in pathologic bones under simple and complex loading. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 30:1032–1039, 2012

1 September 2014 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
WOWendy Oakden
Wendy Oakden
Jacek KwiecienJacek Kwiecien
Jacek Kwiecien
MOMeaghan A. O’rEilly
Meaghan A. O’rEilly
ELEvelyn M.R. Lake
Evelyn M.R. Lake
MAMargarete Akens
Margarete Akens
GSGreg J. Stanisz
Greg J. Stanisz

8 September 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGSoroush Ghomashchi
Soroush Ghomashchi
CWCari M. Whyne
Cari M. Whyne
TCTricia Chinnery
Tricia Chinnery
FHFayez Habach
Fayez Habach
MAMargarete Akens
Margarete Akens
Thermal therapies such as radiofrequency ablation (RFA) are gaining widespread clinical adoption in the local treatment of skeletal metastases. RFA has been shown to successfully destroy tumor cells, yet the impact of RFA on the quality of the surrounding bone has not been well characterized. RFA treatment was performed on femora of rats with bone metastases (osteolytic and osteoblastic) and healthy age matched rats. Histopathology, second harmonic generation imaging and backscatter electron imaging were used to characterize changes in the structure, organic and mineral components of the bone after RFA. RFA treatment was shown to be effective in targeting tumor cells and promoting subsequent new bone formation without impacting the surrounding bone negatively. Mineralization profiles of metastatic models were significantly improved post-RFA treatment with respect to mineral content and homogeneity, suggesting a positive impact of RFA treatment on the quality of cancer involved bone. Evaluating the impact of RFA on bone quality is important in directing the growth of this minimally invasive therapeutic approach with respect to fracture risk assessment, patient selection, and multimodal treatment planning.

11 February 2022 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
ACAdele Changoor
Adele Changoor
RSR. Peter Suderman
R. Peter Suderman
IAIbrahim Alshaygy
Ibrahim Alshaygy
AFAriel Fuhrmann
Ariel Fuhrmann
MAMargarete Akens
Margarete Akens
PKPaul R. T. Kuzyk
Paul R. T. Kuzyk

1 September 2014 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
MAMargarete Akens
Margarete Akens
LWLisa Wise-Milestone
Lisa Wise-Milestone
EWEmily Won
Emily Won
JSJoerg Schwock
Joerg Schwock
AYAlbert J.M. Yee
Albert J.M. Yee
CWCari Whyne
Cari Whyne